The Global Generic Drugs Market, valued at USD 487.21 Billion in 2024, is poised to reach USD 898 Billion by 2035, advancing ...
The Food and Drug Monitoring Agency (BPOM) has issued the first generic drug permit in Indonesia containing dydrogesterone.
The global generic drugs market revenue was around US$ 416.5 billion in 2023 and is estimated to reach US$ 839.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.1% during the ...
The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making ...
Mumbai: About 25 lakh Indians living with HIV have partners who could have been protected from infection by nearly 100% with a twice-yearly lenacapavi.
6d
India’s Generic Pharmacy Revolution: Modi Govt’s Jan Aushadhi Kendra Sales Jump 177-Fold In 11 Years
From Mann Ki Baat to rallies, PM Modi often cites Jan Aushadhi Kendras as an example of how ordinary families can save money and how affordable healthcare can be delivered at scale ...
To soften the blow, CSPC has accelerated its shift from generic drugs to innovative medicines. In the first three quarters, ...
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the ...
The Ministry of Health, Labour and Welfare ("the MHLW") currently lacks sufficient legal experience to assess whether a generic product will, ...
Zydus Lifesciences said that it has received final approval from the US Food and Drug Administration (USFDA) for its Verapamil Hydrochloride Extended-Release Tablets USP in 120 mg, 180 mg and 240 mg ...
According to a filing with the U.S. Securities and Exchange Commission dated November 17, 2025, Westshore Wealth, LLC ...
Discover why UroGen Pharma (URGN) is rated a strong buy for 2026, with innovative cancer therapies and high growth potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback